Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Lancet Oncol. 2020 Aug;21(8):1089–1098. doi: 10.1016/S1470-2045(20)30316-8

Table 3:

Five-year net survival by income group and region under various policies that expand availability of single imaging modalities to the mean level of high-income countries, means (95% UI)

Baseline Ultrasound CT (+X-ray) MRI PET SPECT
Global Survival (%) 42·1
(33·8–48·5)
42·3
(34·0–48·7)
42·5
(34·0–48·8)
42·7
(34·0–49·9)
42·4
(34·0–48·8)
42·2
(33·8–48·6)
Gain (%) --- 0·2
(0·0–1·1)
0·4
(0·0–1·2)
0·6
(0·1–2·1)
0·3
(0·0–0·8)
0·1
(0·0–0·2)

Low income Survival (%) 4·4
(0·4–16·4)
4·9
(0·4–19·7)
4·5
(0·4–17·0)
4·5
(0·4–17·0)
4·4
(0·4–16·4)
4·4
(0·4–16·4)
Gain (%) --- 0·5
(0·0–3·7)
0·2
(0·0–0·9)
0·1
(0·0–0·6)
0·0
(0·0–0·1)
0·0
(0·0–0·0)
Lower middle income Survival (%) 28·5
(7·5–45·5)
28·9
(7·6–45·5)
29·0
(7·5–45·7)
29·3
(7·7–47·3)
28·8
(7·5–45·6)
28·6
(7·5–45·5)
Gain (%) --- 0·3
(0·0–2·4)
0·5
(0·0–2·1)
0·8
(0·0–3·1)
0·3
(0·0–1·2)
0·0
(0·0–0·1)
Upper middle income Survival (%) 61·1
(56·2–66·8)
61·1
(56·2–66·8)
61·5
(56·2–67·0)
61·9
(56·7–67·3)
61·6
(56·6–67·5)
61·2
(56·5–66·8)
Gain (%) --- 0·0
(0·0–0·1)
0·4
(0·0–1·5)
0·8
(0·0–3·3)
0·5
(0·0–1·9)
0·1
(0·0–0·4)
High income Survival (%) 66·0
(64·2–68·2)
66·0
(64·2–68·2)
66·1
(64·3–68·2)
66·1
(64·3–68·4)
66·2
(64·4–68·3)
66·0
(64·3–68·2)
Gain (%) --- 0·0
(0·0–0·0)
0·1
(0·0–0·6)
0·1
(0·0–0·6)
0·2
(0·0–0·8)
0·0
(0·0–0·3)

Africa Survival (%) 13·5
(7·4–20·9)
13·9
(7·5–21·8)
13·7
(7·4–21·6)
13·8
(7·4–21·5)
13·6
(7·5–21·1)
13·5
(7·4–21·0)
Gain (%) --- 0·5
(0·0–2·2)
0·3
(0·0–0·8)
0·4
(0·0–1·6)
0·1
(0·0–0·6)
0·0
(0·0–0·1)
Asia Survival (%) 46·4
(33·1–56·9)
46·6
(33·1–56·9)
46·7
(33·1–57·2)
47·2
(33·2–58·9)
46·7
(33·1–57·2)
46·5
(33·1–56·9)
Gain (%) --- 0·2
(0·0–1·5)
0·3
(0·0–1·4)
0·8
(0·0–2·8)
0·3
(0·0–1·0)
0·1
(0·0–0·3)
Europe Survival (%) 58·1
(53·8–62·2)
58·1
(53·8–62·2)
58·4
(54·0–62·5)
58·7
(54·1–63·9)
58·6
(54·0–62·7)
58·1
(53·9–62·4)
Gain (%) --- 0·0
(0·0–0·2)
0·3
(0·0–2·2)
0·6
(0·0–3·1)
0·5
(0·0–1·8)
0·0
(0·0–0·3)
Latin America and the Caribbean Survival (%) 56·2
(49·9–61·8)
56·2
(49·9–61·8)
57·0
(50·2–62·8)
56·5
(50·0–64·0)
56·8
(50·6–62·5)
56·3
(49·9–61·9)
Gain (%) --- 0·0
(0·0–0·3)
0·8
(0·0–3·4)
0·3
(0·0–3·2)
0·6
(0·0–2·5)
0·1
(0·0–0·5)
Northern America Survival (%) 64·9
(60·1–70·6)
64·9
(60·1–70·6)
64·9
(60·1–70·6)
64·9
(60·1–70·6)
64·9
(60·1–70·6)
65·0
(60·3–70·7)
Gain (%) --- 0·0
(0·0–0·0)
0·0
(0·0–0·1)
0·0
(0·0–0·0)
0·0
(0·0–0·0)
0·1
(0·0–0·7)
Oceania Survival (%) 40·7
(27·3–61·9)
40·9
(27·3–61·9)
41·1
(27·3–62·4)
40·8
(27·3–62·6)
40·9
(27·3–62·1)
40·7
(27·4–61·9)
Gain (%) --- 0·3
(0·0–2·9)
0·4
(0·0–3·2)
0·2
(0·0–1·0)
0·2
(0·0–1·6)
0·1
(0·0–0·5)